Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy P Mallari

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzainNaoaki Fujii, Jeremy P Mallari, Elizabeth J Hansell, et al.
Chemical Biology & Drug Design|June 21, 2006
Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma bruceiZachary B Mackey, Arthur M Baca, Jeremy P Mallari, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2018
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial proteaseJeffrey P Chance, Hannah Fejzic, Obiel Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2020
Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysinGulbag Kahlon, Rogelio Lira, Nikolay Masvlov, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzainNaoaki Fujii, Jeremy P Mallari, Elizabeth J Hansell, et al.
Chemical Biology & Drug Design|June 21, 2006
Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma bruceiZachary B Mackey, Arthur M Baca, Jeremy P Mallari, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2018
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial proteaseJeffrey P Chance, Hannah Fejzic, Obiel Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2020
Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysinGulbag Kahlon, Rogelio Lira, Nikolay Masvlov, et al.
Pageof 2